Bubenik; Monica

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bubenik; Monica.The latest application filed is for "imidazopyridazines useful as inhibitors of the par-2 signaling pathway".

Company Profile

1.10.15

Bubenik; Monica - Mascouche CA
Bubenik; Monica - Quebec CA
Bubenik; Monica - Montreal CA
Bubenik; Monica - Laval CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Imidazopyridazines Useful As Inhibitors Of The Par-2 Signaling Pathway App 20190119282 - Farmer; Luc J. ; et al.	2019-04-25
Imidazopyridazines useful as inhibitors of the PAR-2 signaling pathway Grant 10,030,024 - Farmer , et al. July 24, 2	2018-07-24
Bicyclic Heteroaryl Compounds Useful As Inhibitors Of The Par-2 Signaling Pathway App 20180057505 - SAYEGH; Camil Elie ; et al.	2018-03-01
Imidazopyridazines Useful As Inhibitors Of The Par-2 Signaling Pathway App 20160311825 - Farmer; Luc J. ; et al.	2016-10-27
Benzimidazole Analogues For The Treatment Or Prevention Of Flavivirus Infections App 20140243257 - Henderson; James A. ; et al.	2014-08-28
Benzimidazole analogues for the treatment or prevention of flavivirus infections Grant 8,765,731 - Henderson , et al. July 1, 2	2014-07-01
Benzimidazole Analogues For The Treatment Or Prevention Of Flavivirus Infections App 20130157997 - Henderson; James A. ; et al.	2013-06-20
Analogues For The Treatment Or Prevention Of Flavivirus Infections App 20130072523 - Liu; Bingcan ; et al.	2013-03-21
Benzimidazole analogues for the treatment or prevention of flavivirus infections Grant 8,354,419 - Henderson , et al. January 15, 2	2013-01-15
Lupane derivatives useful for treating HIV Grant 8,269,026 - Moinet , et al. September 18, 2	2012-09-18
Spirotropane compounds Grant 8,124,613 - Moinet , et al. February 28, 2	2012-02-28
Spirotropane compounds and methods for the modulation of chemokine receptor activity Grant 8,076,349 - Chan Chun Kong , et al. December 13, 2	2011-12-13
Benzimidazole Analogues For The Treatment Or Prevention Of Flavivirus Infections App 20110172238 - Henderson; James A. ; et al.	2011-07-14
Spirotropane compounds and methods for the modulation of chemokine receptor activity Grant 7,960,403 - Chan Chun Kong , et al. June 14, 2	2011-06-14
Spirotropane Compounds App 20110105546 - Moinet; Christophe ; et al.	2011-05-05
Novel 17 Beta Lupane Derivatives App 20110077251 - Moinet; Christophe ; et al.	2011-03-31
Novel Lupane Derivatives App 20110077227 - Moinet; Christophe ; et al.	2011-03-31
Spirohydantoin Compounds And Methods For The Modulation Of Chemokine Receptor Activity App 20100286183 - CHAN CHUN KONG; Laval ; et al.	2010-11-11
Spirohydantoin compounds and methods for the modulation of chemokine receptor activity Grant 7,709,642 - Chan Chun Kong , et al. May 4, 2	2010-05-04
Novel Spirotropane Compounds And Methods For The Modulation Of Chemokine Receptor Activity App 20090047238 - Chan Chun Kong; Laval ; et al.	2009-02-19
Novel Spirotropane Compounds and Methods for the Modulation of Chemokine Receptor Activity App 20080267906 - Chan Chun Kong; Laval ; et al.	2008-10-30
Spirohydantoin compounds and methods for the modulation of chemokine receptor activity App 20060014769 - Kong; Laval Chan Chun ; et al.	2006-01-19
Thiophene integrin inhibitors Grant 6,274,620 - Labrecque , et al. August 14, 2	2001-08-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.